-
1 Comment
Al-'Aqar Healthcare REIT is currently in a long term downtrend where the price is trading 2.8% below its 200 day moving average.
From a valuation standpoint, the stock is 29.2% more expensive than other stocks from the Other sector with a price to sales ratio of 8.3.
Al-'Aqar Healthcare REIT's total revenue rose by 53.9% to $41M since the same quarter in the previous year.
Its net income has dropped by 194.0% to $-27M since the same quarter in the previous year.
Finally, its free cash flow grew by 18.6% to $42M since the same quarter in the previous year.
Based on the above factors, Al-'Aqar Healthcare REIT gets an overall score of 2/5.
| ISIN | MYL5116TO007 |
|---|---|
| Sector | Real Estate |
| Industry | REIT - Healthcare Facilities |
| CurrencyCode | MYR |
| Exchange | KLSE |
| Beta | 0.05 |
|---|---|
| Market Cap | 1B |
| PE Ratio | 18.0 |
| Target Price | 1.26 |
| Dividend Yield | 5.6% |
Al-`Aqar Healthcare REIT ("'Al-`Aqar") was established on 10 August 2006 and is listed on the main market of Bursa Malaysia. From its humble beginnings with a portfolio of just six properties, Al-`Aqar has steadily evolved and transformed into a reputable player in the Malaysian REIT landscape. Today, it boasts an extensive portfolio of 23 properties strategically diversified across several key segments, with a notable focus on healthcare assets. The portfolio now comprises 17 hospitals, three wellness/ health centers, two colleges, and an aged care facility, underscoring Al-`Aqar's robust position in the healthcare real estate sector. This diverse mix of properties not only highlights the fund's adaptability but also its ability to cater to the growing demand for specialised healthcare and wellness services in Malaysia. Al-`Aqar's growth trajectory has been driven by the expertise and strong leadership of JLG REIT Managers Sdn Bhd (JRM) (formerly known as Damansara REIT Managers Sdn Berhad), which serves as the fund manager. JRM is a wholly-owned subsidiary of Johor Corporation and is further supported by KPJ Healthcare Berhad ("'KPJ"), both of which provide a solid foundation for Al-`Aqar's strategic direction and operational success. JRM's dedicated efforts in asset management, operational efficiency, and portfolio optimisation have been instrumental in the fund's continued success and expansion. As of 31 December 2024, Al-`Aqar's portfolio is valued at RM1.65 billion, with a market capitalisation of RM1.14 billion.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 5116.KLSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
